Skip to main content
Elsevier
View Cart

Books in Carcinogenesis

BooksJournals

    • Nutritional Oncology

      • 2nd Edition
      • April 7, 2006
      • David Heber + 3 more
      • English
      • Hardback
        9 7 8 0 1 2 0 8 8 3 9 3 6
      • eBook
        9 7 8 0 0 8 0 4 5 4 1 7 7
      Nutritional oncology is an increasingly active interdisciplinary field where cancer is investigated as both a systemic and local disease originating with the changes in the genome and progressing through a multi-step process which may be influenced at many points in its natural history by nutritional factors that could impact the prevention of cancer, the quality of life of cancer patients, and the risk of cancer recurrence in the rapidly increasing population of cancer survivors.Since the first edition of this book was published in 1999, the idea that there is a single gene pathway or single drug will provide a cure for cancer has given way to the general view that dietary/environmenta... factors impact the progression of genetic and cellular changes in common forms of cancer. This broad concept can now be investigated within a basic and clinical research context for specific types of cancer. This book attempts to cover the current available knowledge in this new field of nutritional oncology written by invited experts. This book attempts to provide not only the theoretical and research basis for nutritional oncology, but will offer the medical oncologist and other members of multidisciplinary groups treating cancer patients practical information on nutrition assessment and nutritional regimens, including micronutrient and phytochemical supplementation. The editors hope that this volume will stimulate increased research, education and patient application of the principles of nutritional oncology.NEW TO THIS EDITION:* Covers hot new topics of nutrigenomics and nutrigenetics in cancer cell growth * Includes new chapters on metabolic networks in cancer cell growth, nutrigenetics and nutrigenomics* Presents substantially revised chapters on breast cancer and nutrition, prostate cancer and nutrition, and colon cancer and nutrition* Includes new illustrations throughout the text, especially in the breast cancer chapter

    • Cancer Immunotherapy

      • 1st Edition
      • Volume 90
      • April 3, 2006
      • James Allison + 1 more
      • English
      • Paperback
        9 7 8 0 1 2 4 1 1 1 3 7 0
      • Hardback
        9 7 8 0 1 2 0 2 2 4 8 9 0
      • eBook
        9 7 8 0 0 8 0 4 6 3 3 7 7
      For some time immunotherapy has been heralded as a breakthrough approach for cancer treatment. Although the potential of this strategy remains solid, the approach needs considerable refinement. Whilst some programmes are looking to increase the understanding of molecular and cellular mechanisms underlying the stimulation of antitumor immunity, others are trying to find the most appropriate clinical setting that will reveal the role of the immune system in combating cancer. Among the most important discoveries have been tumor-specific antigens. This thematic volume highlights some key issues and discusses where they may move forward. It has been put together by two leading cancer immunotherapists from two eminent institutions that focus on cancer research.

    • Advances in Cancer Research

      • 1st Edition
      • Volume 94
      • May 31, 2005
      • George F. Vande Woude + 1 more
      • English
      • eBook
        9 7 8 0 0 8 0 4 5 8 9 0 8
      The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics including Molecular Mechanisms in Gliomagenesis; Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting; Mitochondria as Functional Targets of Proteins Coded by Human Tumor Viruses; Apoptotic Pathways and Therapy Resistance in Human Malignancies; Endostatin Signaling and Regulation of Endothelial Cell-Matrix Interactions; Molecular Mechanisms and Clinical Development.

    • Thyroid Neoplasms

      • 1st Edition
      • Volume 4
      • April 8, 2005
      • Bryan Haugen
      • English
      • Hardback
        9 7 8 0 4 4 4 5 0 9 5 2 9
      • Paperback
        9 7 8 0 4 4 4 5 4 7 5 8 3
      • eBook
        9 7 8 0 0 8 0 4 5 8 8 0 9
      This is a unique book on thyroid neoplasms in that it covers many current topics in the area including tumor development, tumor markers and preclinical treatment for advanced cancer as well as practical approaches (radioiodine, ultrasound, thyroglobulin monitoring and PET scanning). This book will give the general reader and specialist a good foundation for what is currently going on in the area of thyroid neoplasms.

    • Cancers in the Urban Environment

      • 1st Edition
      • June 28, 2004
      • Thomas M. Mack
      • English
      • eBook
        9 7 8 0 0 8 0 5 2 8 4 6 5
      This volume, the first of its kind ever, is designed to provide both laypersons and professionals with a detailed description of the occurrence of each common form of cancer in the ethnically, socially, and environmentally complex milieu of a modern urban complex. The place is Los Angeles County, and the patterns of 72 different malignancies are described according to race, age, sex, social class calendar time (since 1972) and most notably, individual neighborhood, using detailed maps of high risk.The book permits residents to screen the malignancies and identify those of special concern locally, and to identify other communities with similar concerns. The pattern of each malignancy is briefly discussed with reference to background knowledge of causation and the degree to which the observed pattern was expected on that basis. Persons residing outside Los Angeles County will identify patterns likely to prevail in their own communities.Physicia... and scientific investigators in California and elsewhere can use the material provided to counsel patients and evaluate the consistency of any specific pattern of occurrence with each specific causal hypothesis. A detailed appendix describes the source of data, provides the basis for the choices made in the production of the volume, and gives a perspective on the search for “clusters” of malignancy.

    • Genetic Recombination in Cancer

      • 1st Edition
      • July 24, 2003
      • Gajanan V. Sherbet
      • English
      • Hardback
        9 7 8 0 1 2 6 3 9 8 8 1 6
      • Paperback
        9 7 8 0 1 2 3 9 0 9 4 3 5
      • eBook
        9 7 8 0 0 8 0 5 2 1 9 0 9
      Genetic recombination is a process of combining genes that leads to the generation of cell variants that possess different characteristics. This process is important to the evolution of a species and to embryonic growth and differentiation. However, this process can also lead to the development of abnormal, cancerous cells. This book reviews the role of genetic recombination in the generation of various cancers and how genetic alterations have been or could be employed to elicit clinically useful information.

    • Prostate Cancer

      • 1st Edition
      • July 11, 2003
      • Jack H. Mydlo + 1 more
      • English
      • Hardback
        9 7 8 0 1 2 2 8 6 9 8 1 5
      • eBook
        9 7 8 0 0 8 0 4 9 7 8 9 1
      An important translational book bridging the gap between science and clinical medicine, Prostate Cancer reviews the biological processes that can be implicated in the disease, reviews current treatments, highlighting the pitfalls where relevant and examines the scientific developments that might result in novel treatments in the future.

    • Anticancer Drug Development

      • 1st Edition
      • October 15, 2001
      • Bruce C. Baguley + 1 more
      • English
      • Paperback
        9 7 8 0 1 2 3 9 1 1 2 7 8
      • Hardback
        9 7 8 0 1 2 0 7 2 6 5 1 6
      • eBook
        9 7 8 0 0 8 0 4 9 0 4 4 1
      Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of multidisciplinary fields of research, this book offers a wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death. Detailed descriptions of sources for new drugs and methods for testing and clinical trial design are also provided.

    • The Oncobiology of the Prostate

      • 1st Edition
      • Volume 3
      • December 20, 2000
      • D.P. Wood + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 4 5 4 1 6 6 6
      • eBook
        9 7 8 0 0 8 0 5 3 7 9 9 3
      Prostate cancer (PCa) is the most common newly diagnosed cancer among men in the United States today. With the advent of the prostate-specific antigen (PSA) test, the number of newly diagnosed cases has increased tremendously. The rates of PCa have increased so dramatically over the last decade that the age-adjusted incidence rate of PCa is no greater than that for any other cancer among men in the United States. Although PCa rates have risen steadily since 1973, there has been a dramatic acceleration in the late 1980s which has been associated with the introduction and use of PSA for screening and early detection. There is now some evidence that the rates may be levelling off and even decreasing in some areas. After lung cancer, PCa is the leading cause of death due to cancer in men in the United States. Although PCa can occur in younger men, it is essentially a cancer of elderly men. The highest rates of PCa in the world occur among African-American men in the United States. African-Americans have higher rates than Caucasians at all age levels in the United States, and adjusting for social-economic status does not appear to account for this difference to any appreciable extent. There is no clear reason why PCa rates are so much greater among African-Americans compared with Caucasians in the United States. The reported rates in Africans are substantially lower than those of an African-American, suggesting that environmental factors have an influence on PCa. In spite of this substantial impact on our society. PCa remains a relatively understudied disease, with an essentially unknown etiology. The reviews contained in this book are by no means exhaustive. We have, however, attempted to provide information regarding the pathology of prostate cancer, the status of diagnostic and prognostic markers, as well as a discussion of our understanding of the molecular basis for the disease. The biology of prostate cancer is covered with a discussion on the role of apoptosis in prostate cancer and the suggestion of it being the target for new therapeutic development, as well as the role played by integrins and angiogenesis. The status of current therapies, both hormonal and chemotherapy, are also discussed. This volume should provide a useful background for individuals wishing to commence an in-depth understanding of prostate cancer.

    • Cancer Metastasis: Experimental Approaches

      • 1st Edition
      • Volume 29
      • December 11, 2000
      • D. Rusciano + 1 more
      • D.R. Welch
      • English
      • Hardback
        9 7 8 0 4 4 4 8 2 3 7 2 4
      • Paperback
        9 7 8 0 4 4 4 8 2 3 5 8 8
      • eBook
        9 7 8 0 0 8 0 9 3 3 3 7 5
      The book describes most of the methods that are currently used in metastasis research. Both in vivo and in vitro protocols are illustrated, so that the metastatic process can be either analysed as a whole, or single events addressed separately. Each method is described in the frame of the metastatic process, therefore its significance and its limitations in the context of metastasis are always taken into account. Whenever possible, several alternative procedures are reported per each experimental issue, so that the researcher can choose the one that better suits her/his needs and possibilities.During the past 30 years a big effort has been made to elucidate the molecular mechanisms of cancer metastatis, the leading cause of death for cancer patients. A considerable number of assays have been set up, that can be used to address specific questions concerning the single metastatic steps, or can be applied to develop and test drugs specifically interfering with selected events during the metastatic spread. This book contains an exhaustive description of most of the methods and their rationale, that are currently used in metastatic research, both to analyse metastasis in its entirety (in vivo models), or to dissect the single steps of the metastatic process (in vitro assays).